Search Results 891-900 of 18939 for creatine

1. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

2. A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

   Patients with end stage renal function (creatinine clearance (CrCl) < 15 mL/min or glomerular filtration rate < 15 mL/min), regardless of whether hemodialysis ...

3. Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= 70 mL/min/1.73 m^2 or normal serum creatinine based on age/gender as follows: 2 to ...

4. Giant Cell Arteritis Vessel Wall Enhancement - Mayo Clinic

   Participants who are receiving a clinically-indicated MRI at the time of enrollment may participate even if they meet exclusion criteria of creatinine clearance ...

5. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   × ULN, if liver metastases are present). 9. Has adequate renal function, defined as serum creatinine ≤ 1.5 × ULN or creatinine clearance ≥ 30 mL/minute ...

6. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Serum creatinine ≤1.5 mg/dL and /or estimated creatinine clearance (eClCR) ≥30mL/min by the Cockcroft-Gault formula [see Appendix 13.4]). Negative ...

7. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

   Creatinine ≤ 1.5 x institutional ULN; OR; Glomerular filtration rate (GFR) ≥ 45 mL/min/1.73 m^2. Human immunodeficiency virus (HIV)-infected patients on ...

8. A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   Creatinine clearance <40 mL/minute, calculated using the Cockcroft-Gault formula; Use of following therapies within 4 weeks of randomization (Day 1/Visit 2) ...

9. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

   Serum creatinine ≤1.5 × ULN set by the site and creatinine clearance >30 mL/min using Cockroft formula. Relevant toxicities of prior therapies must have ...

10. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion - Mayo Clinic

    Chronic kidney disease with creatinine clearance of less than 30mL/min; History of antiphospholipid syndrome, in particular triple positive (lupus ...